Production (Stage)
ANI Pharmaceuticals, Inc.
ANIP
$57.79
$0.520.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.66% | -1.38% | -37.96% | 3.69% | 7.75% |
| Total Receivables | -0.63% | 12.92% | 18.22% | -3.67% | 6.38% |
| Inventory | 0.46% | -7.61% | 18.01% | 10.20% | 2.38% |
| Prepaid Expenses | 30.10% | 2.89% | 26.09% | -13.01% | -9.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.43% | -96.32% | 100.16% | 955.67% | -96.26% |
| Total Current Assets | 1.63% | 1.23% | -6.15% | 2.76% | 3.99% |
|
|
|||||
| Total Current Assets | 1.63% | 1.23% | -6.15% | 2.76% | 3.99% |
| Net Property, Plant & Equipment | 2.31% | 0.28% | 9.81% | 6.42% | 8.82% |
| Long-term Investments | 1.12% | -0.72% | 114.12% | 0.00% | 0.00% |
| Goodwill | 1.12% | -0.72% | 114.12% | 0.00% | 0.00% |
| Total Other Intangibles | -0.62% | -4.91% | 211.25% | -6.61% | -6.20% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.90% | 22.38% | -20.46% | 1.58% | -3.18% |
| Total Assets | 0.68% | -0.29% | 39.82% | 0.68% | 1.12% |
|
|
|||||
| Total Accounts Payable | 16.21% | -25.02% | 25.08% | -1.52% | 34.75% |
| Total Accrued Expenses | -11.10% | 8.64% | 49.96% | 32.83% | -27.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.16% | 56.75% | 741.41% | 0.00% | 0.00% |
| Total Finance Division Other Current Liabilities | 23.51% | 20.08% | 10.40% | -22.23% | -10.85% |
| Total Other Current Liabilities | 23.51% | 20.08% | 10.40% | -22.23% | -10.85% |
| Total Current Liabilities | 4.20% | 1.97% | 35.69% | 2.26% | -5.90% |
|
|
|||||
| Total Current Liabilities | 4.20% | 1.97% | 35.69% | 2.26% | -5.90% |
| Long-Term Debt | -0.54% | -0.53% | 117.38% | -0.07% | -0.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 54.32% | -34.49% | 48.41% | -7.44% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -32.19% | 1.27% | 274.06% | -0.61% | -32.47% |
| Total Liabilities | -0.73% | -0.16% | 94.61% | 0.56% | -2.04% |
|
|
|||||
| Common Stock & APIC | 2.19% | 1.71% | -4.06% | 1.69% | 1.85% |
| Retained Earnings | 15.23% | -11.92% | -37.79% | -4.32% | 22.21% |
| Treasury Stock & Other | -74.78% | -2.21% | -31.09% | -25.47% | -662.75% |
| Total Common Equity | 3.70% | -0.56% | -10.93% | 0.84% | 4.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 3.70% | -0.56% | -10.93% | 0.84% | 4.44% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.49% | -0.53% | -10.36% | 0.80% | 4.20% |
|
|
|||||